Trials / Terminated
TerminatedNCT00157846
X-Change HF - Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure
Exchange of the Existing Pacemaker/ICD in Bradycardia Patients Suffering From Heart Failure to Investigate the Effect of Preventive Stimulation
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Medtronic Cardiac Rhythm and Heart Failure · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The goal of X-Change HF is to estimate the effect of biventricular stimulation in patients who need antibradycardia ventricular stimulation (more than 80%); are eligible for the exchange of an old pacemaker or implantable cardioverter defibrillator (ICD); and have ventricular dysfunction (left ventricular ejection fraction \[LVEF\] \< 35%). All patients eligible for participation in the study will be upgraded with a cardiac resynchronization therapy (CRT)-device and receive either right ventricular or biventricular stimulation in a crossover protocol. The endpoint is functional performance measured by spiroergometry.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | CRT-P or CRT-D Device | Upgrade from ICD or pacemaker to CRT-D/CRT-P (Insync III, Insync Marquis, Insync Sentry, Insync Maximo, Concerto) |
Timeline
- Start date
- 2003-10-01
- Primary completion
- 2008-08-01
- Completion
- 2008-08-01
- First posted
- 2005-09-12
- Last updated
- 2025-07-03
Locations
10 sites across 1 country: Germany
Source: ClinicalTrials.gov record NCT00157846. Inclusion in this directory is not an endorsement.